KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 334 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $113,143,779 | +2844.9% | 357,473 | +1473.2% | 1.23% | +2633.3% |
Q3 2023 | $3,842,063 | -64.6% | 22,722 | -54.6% | 0.04% | -65.1% |
Q2 2023 | $10,864,185 | +231.1% | 50,100 | +243.5% | 0.13% | +180.4% |
Q3 2022 | $3,281,000 | -82.3% | 14,585 | -90.1% | 0.05% | -83.9% |
Q2 2022 | $18,563,000 | +70.3% | 146,735 | +70.6% | 0.29% | +61.6% |
Q1 2022 | $10,903,000 | +396.5% | 85,990 | +412.9% | 0.18% | +471.0% |
Q4 2021 | $2,196,000 | +68.3% | 16,764 | +57.1% | 0.03% | +47.6% |
Q3 2021 | $1,305,000 | +7.3% | 10,668 | 0.0% | 0.02% | -8.7% |
Q2 2021 | $1,216,000 | -5.2% | 10,668 | 0.0% | 0.02% | -17.9% |
Q1 2021 | $1,283,000 | – | 10,668 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |